Alkermes Announces Initiation of Vibrance-3 Phase 2 Study Evaluating ALKS 2680 for the Treatment of Idiopathic Hypersomnia
Alkermes plc (Nasdaq: ALKS) today announced the initiation of Vibrance-3, a phase 2 clinical study evaluating the safety and efficacy of ALKS 2680 compared to placebo in adults with idiopathic ...
Onlymyhealth4d
Does Idiopathic Hypersomnia Ever Go Away? Find Out From The Expert
Idiopathic hypersomnia is a neurological sleep disorder characterised by excessive daytime sleepiness despite getting a full ...
American Association of Individual Investors26m
Which Is a Better Investment, Jazz Pharmaceuticals plc or Viatris Inc. Stock?
Learn more about whether Jazz Pharmaceuticals plc or Viatris Inc. is a better investment based on AAII's A+ Investor grades, ...
Bronstein, Gewirtz & Grossman, LLC Is Investigating Harmony Biosciences Holdings, Inc. (HRMY) And Encourages Investors to Connect
NEW YORK, NY / ACCESS Newswire / April 1, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on ...
Bronstein, Gewirtz & Grossman, LLC Encourages Harmony Biosciences Holdings, Inc. (HRMY) Stockholders to Inquire about Securities Investigation
NEW YORK, NY / ACCESS Newswire / March 31, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on ...
Sei Investments Co. Has $7.54 Million Stock Holdings in Jazz Pharmaceuticals plc (NASDAQ:JAZZ)
Sei Investments Co. decreased its stake in Jazz Pharmaceuticals plc (NASDAQ:JAZZ – Free Report) by 30.5% in the 4th quarter, ...
This Animal Sleeps a Whopping 23 Hours Every Day
Despite decades of research, scientists admit that they still have a lot to learn about sleep. In general, sleep can be ...
UVA Today4d
UVA Health Takes Aim at Long COVID in Two National Clinical Trials
UVA Health recently joined two national clinical trials that are part of the National Institutes of Health’s Researching ...